Peripheral Vascular Devices Market Size, Share, Growth and Industry Analysis, By Types (Catheters, Angioplasty Balloons, Angioplasty Stents, EVAR Stent Grafts, Inferior Vena Cava Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others), By Applications (The Treatment of Peripheral Blood Vessels Damaged, The Treatment of Peripheral Blood Vessels Blockage), Regional Insights and Forecast to 2035

Peripheral Vascular Devices Market Size

The Global Peripheral Vascular Devices Market was valued at USD 15.97 Billion in 2025 and is expected to grow to USD 16.94 Billion in 2026, eventually reaching USD 28.76 Billion by 2035. This progression indicates a CAGR of 6.06% during the projected period from 2026 to 2035. Market growth is driven by the increasing global prevalence of peripheral arterial disease, which accounts for a substantial share of vascular interventions. Additionally, more than 60% of hospitals worldwide now utilize minimally invasive vascular procedures, with angioplasty and stenting together representing over 55% of total vascular device applications.

The U.S. Peripheral Vascular Devices Market holds a major portion of global demand, with over 35% share attributed to advanced healthcare infrastructure and increasing adoption of outpatient vascular procedures. More than 65% of vascular specialists in the U.S. now perform endovascular interventions as first-line treatment. Additionally, over 50% of regional investment in cardiovascular equipment is directed toward peripheral applications, reflecting growing awareness and early diagnosis rates. Outpatient surgical centers are contributing to more than 40% of all peripheral interventions in the country.

Key Findings

• Market Size: Valued at $15.97Bn in 2025, projected to touch $16.94Bn in 2026 to $28.76Bn by 2035 at a CAGR of 6.06%.
• Growth Drivers: Over 60% increase in endovascular adoption and 55% shift toward minimally invasive peripheral revascularization solutions.
• Trends: More than 45% demand growth in drug-coated balloons and over 35% development in AI-assisted vascular imaging tools.
• Key Players: Medtronic, Boston Scientific Corporation, Abbott Laboratories, Terumo Corporation, Becton Dickinson & more.
• Regional Insights: North America holds 35% share due to advanced infrastructure, Europe follows with 30% driven by public health programs, Asia-Pacific accounts for 25% from rising demand, and Middle East & Africa captures 10% with improving medical access.
• Challenges: Over 55% of companies face regulatory complexity and 45% of facilities in low-income regions report limited device access.
• Industry Impact: More than 50% shift from traditional to outpatient vascular procedures and over 40% increase in diagnostic accuracy through imaging integration.
• Recent Developments: Over 35% of launches involve bioresorbable materials, 40% feature real-time imaging, and 30% target ambulatory centers.

The Peripheral Vascular Devices Market is undergoing a significant transformation with rising adoption of next-generation devices that combine imaging guidance and drug-eluting capabilities. Over 50% of product development is now focused on improving procedural precision and patient recovery time. This evolution aligns with the rising shift toward outpatient care, which accounts for nearly 60% of peripheral interventions in urban centers. Regulatory shifts and AI-driven innovation continue to reshape device performance, while emerging markets are witnessing a 30% rise in demand for compact vascular systems.

Peripheral Vascular Devices Market Trends

The Peripheral Vascular Devices Market is experiencing rapid growth, driven by a rising incidence of peripheral arterial diseases and a surge in minimally invasive procedures. Approximately 60% of hospitals globally have adopted endovascular devices as a preferred method for peripheral revascularization. Over 55% of peripheral procedures now involve stents, particularly drug-eluting and self-expanding types, due to their increased procedural success rates. More than 45% of vascular specialists report a shift toward atherectomy systems for plaque removal, favoring mechanical over laser technologies. Furthermore, over 35% of the global aging population is diagnosed with chronic conditions that necessitate frequent vascular assessments and interventions. The market is also influenced by the increasing use of balloon angioplasty catheters, which account for more than 40% of peripheral angioplasty procedures. Duplex ultrasound and non-invasive imaging have also seen a usage rise of over 50% in diagnosing vascular blockages. In terms of healthcare expenditure, over 65% of public and private investments are being directed toward vascular care infrastructure and device innovation. Hospitals and outpatient settings represent nearly 70% of peripheral vascular device end-users. Technological advancements, including 3D vascular mapping and biocompatible coating materials, are adopted in over 48% of new devices entering the market. This trend underlines a robust transformation in clinical practices and procurement strategies globally.

Peripheral Vascular Devices Market Dynamics

DRIVERS

Rising prevalence of vascular disorders

More than 65% of patients diagnosed with diabetes and hypertension are at high risk of peripheral vascular diseases, driving demand for early diagnostics and interventional tools. Over 70% of clinicians are recommending advanced endovascular devices due to fewer complications and faster recovery. Additionally, more than 50% of healthcare systems in developed regions are adopting preventive screening programs, further boosting market expansion for diagnostic and therapeutic peripheral vascular devices.

OPPORTUNITY

Growth in outpatient care and ambulatory services

Nearly 60% of peripheral vascular procedures are transitioning from hospitals to outpatient and ambulatory surgical centers due to cost-effectiveness and convenience. Over 50% of these centers are investing in compact, portable vascular imaging and intervention tools. Furthermore, over 40% of new product launches are specifically tailored for minimally invasive outpatient use, unlocking major growth opportunities across urban and semi-urban healthcare facilities globally.

RESTRAINTS

"Limited access in low-income regions"

Over 45% of healthcare facilities in low-income regions report inadequate access to advanced peripheral vascular devices due to infrastructure gaps and procurement limitations. Nearly 50% of healthcare professionals in developing countries rely on outdated diagnostic tools, which limits the adoption of newer minimally invasive solutions. Additionally, more than 40% of public healthcare budgets in these regions are allocated to primary care, leaving peripheral interventions underfunded. This accessibility disparity affects treatment outcomes and slows the market’s growth potential in emerging economies, creating an imbalance in the global expansion of peripheral vascular care solutions.

CHALLENGE

"Rising complexity in regulatory compliance"

Approximately 55% of medical device manufacturers highlight regulatory complexity as a barrier to launching peripheral vascular devices in multiple markets. Over 60% of small to mid-sized companies face approval delays due to region-specific compliance standards. In Europe and parts of Asia, more than 35% of new device applications are delayed due to evolving clinical safety requirements. Additionally, over 50% of market entrants are forced to redesign or retest devices to meet regional certification norms, increasing development cycles and operational costs. These challenges significantly impact innovation speed and market accessibility for next-generation vascular products.

Segmentation Analysis

The Peripheral Vascular Devices Market is segmented based on device type and application, with each category demonstrating unique growth patterns and utilization rates. By type, the market includes various interventional tools such as catheters, angioplasty balloons, and stents that are essential for different vascular procedures. These device types serve specific functions in diagnosing, treating, and managing peripheral vascular conditions. On the other hand, segmentation by application focuses on the treatment of peripheral blood vessels, whether damaged or blocked, offering tailored clinical solutions based on the severity and cause of vascular issues. The increasing demand for minimally invasive interventions has driven the adoption rate of advanced devices across these segments. As healthcare infrastructure improves and awareness rises, both segmentation categories are seeing notable traction, particularly in emerging economies and urban outpatient facilities where nearly 60% of such treatments are conducted.

By Type

• Catheters: Catheters account for over 30% of peripheral interventions due to their widespread use in both diagnostics and therapeutic procedures. Their adoption is driven by versatility and compatibility with various imaging technologies.
• Angioplasty Balloons: Over 28% of procedures involve angioplasty balloons, especially in cases requiring temporary dilation of narrowed vessels. Drug-coated variants are gaining momentum in over 40% of deployments.
• Angioplasty Stents: Angioplasty stents, particularly self-expanding types, are used in more than 35% of peripheral revascularization cases. These devices are favored for long-term vessel patency and minimal restenosis.
• EVAR Stent Grafts: EVAR stent grafts contribute to over 22% of aneurysm repairs, especially abdominal aortic aneurysms. Their minimally invasive nature reduces hospital stays in nearly 45% of surgical cases.
• Inferior Vena Cava Filters: These filters are used in more than 18% of high-risk cases to prevent pulmonary embolism, especially in patients contraindicated for anticoagulants.
• Plaque Modification Devices: These devices are applied in nearly 25% of complex lesion cases where traditional balloons or stents are ineffective, improving procedural outcomes by over 35%.
• Hemodynamic Flow Alteration Devices: Used in over 15% of high-risk arterial interventions, these tools optimize flow dynamics and are integral in patients with recurring stenosis.
• Others: Other devices such as guidewires and sheaths collectively represent around 10% of procedural setups and serve essential supporting roles in vascular interventions.

By Application

• The Treatment of Peripheral Blood Vessels Damaged: More than 40% of procedures address vascular damage from trauma or chronic inflammation. These treatments focus on structural restoration using stents and grafts, especially in cases where over 50% of the vessels show elasticity loss or wall thinning.
• The Treatment of Peripheral Blood Vessels Blockage: Vascular blockages are the most common application, accounting for over 60% of total interventions. Angioplasty and plaque removal are prioritized in over 70% of such cases, with demand surging among patients over the age of 55.

Regional Outlook

The Peripheral Vascular Devices Market displays varied growth across regions due to differences in healthcare infrastructure, aging populations, and adoption of advanced medical technologies. North America holds a dominant share due to higher awareness, reimbursement availability, and technological innovations. Europe follows closely, supported by increased preventive care and vascular disease screening. The Asia-Pacific region is rapidly expanding, led by rising healthcare expenditure and increasing patient population with vascular conditions. Meanwhile, the Middle East & Africa region is experiencing gradual growth, driven by targeted investments in hospital infrastructure and device availability. Each region presents distinct trends that shape the competitive and investment landscape of the market.

North America

North America leads the market with over 35% share, driven by advanced interventional systems, frequent screening programs, and a growing elderly population. More than 60% of hospitals are equipped with next-gen vascular tools, while over 50% of patients with peripheral arterial disease undergo minimally invasive procedures annually. Outpatient vascular centers have seen an increase of over 40% in procedural volume due to quicker recovery protocols.

Europe

Europe holds over 30% of the global share, with strong uptake in Germany, France, and the UK. Nearly 45% of vascular surgeries in Europe involve endovascular devices. Public health initiatives targeting vascular risk factors have reached more than 55% of urban populations. In addition, over 50% of medical device companies in the region focus on biocompatible materials and device miniaturization.

Asia-Pacific

Asia-Pacific shows the fastest growth, contributing nearly 25% of global volume. Rising lifestyle-related diseases affect over 40% of the population, pushing demand for peripheral vascular diagnostics and interventions. Countries like China, India, and Japan see over 50% increase in vascular outpatient visits annually. Investments in rural vascular care infrastructure have grown by over 35%, expanding access across the region.

Middle East & Africa

The Middle East & Africa region accounts for around 10% of the global share. Urban medical centers in countries like the UAE and South Africa perform over 60% of regional vascular procedures. However, access in remote regions remains limited, with less than 40% of facilities having adequate vascular equipment. Despite these challenges, device import rates have grown by over 30%, signaling improving adoption potential.

List of Key Peripheral Vascular Devices Market Companies Profiled

Investment Analysis and Opportunities

Investment in the Peripheral Vascular Devices Market is accelerating due to increasing demand for minimally invasive vascular solutions and the rise in peripheral arterial disease cases worldwide. More than 55% of funding is being channeled into research for drug-coated balloons and bioresorbable stents. Private equity investments in vascular startups have increased by over 40%, especially in the Asia-Pacific region, where emerging economies show high unmet medical needs. Additionally, over 60% of med-tech companies are entering strategic partnerships to co-develop imaging-integrated vascular platforms. Public hospitals are allocating nearly 50% of their capital equipment budget to vascular intervention suites, enhancing access to next-generation tools. Venture funding in AI-based vascular diagnostics has grown by over 35%, indicating a shift towards precision and data-driven interventions. The growing trend of ambulatory care centers investing in compact, mobile vascular units, with a rise of over 30%, also reveals a key opportunity for players targeting outpatient settings.

New Products Development

New product development in the Peripheral Vascular Devices Market is being driven by innovation in stent materials, drug-eluting technologies, and device miniaturization. Over 45% of new product approvals globally are related to advanced stents and balloon catheters, particularly in drug-coated variants. Companies are focusing on biocompatible and biodegradable materials, used in more than 40% of pipeline products. Additionally, more than 35% of new devices are being developed with real-time imaging integration, improving procedural outcomes. Robotic-assisted vascular intervention tools are also gaining momentum, with development investments rising by over 25%. Compact diagnostic devices for outpatient settings represent over 30% of the newly launched tools. Furthermore, AI-powered vascular analysis platforms now make up over 20% of innovative software solutions accompanying hardware. Clinical trials for next-generation plaque modification tools have increased by over 50%, reflecting rising confidence in disruptive therapeutic technologies across global manufacturers.

Recent Developments

• Medtronic launched new drug-coated balloon in 2023: Medtronic introduced an advanced drug-coated balloon with enhanced drug transfer efficiency, which demonstrated a 28% improvement in vessel patency during clinical trials. This product was adopted in over 40% of European vascular centers within six months of release, reinforcing the company's innovation leadership in interventional tools.
• Boston Scientific expanded vascular stent portfolio in 2024: Boston Scientific added a new line of peripheral self-expanding stents, optimized for superficial femoral artery use. The devices, adopted in over 35% of vascular surgeries across North America, feature a flexible nitinol design and have shown a 32% reduction in restenosis compared to previous models.
• Terumo Corporation introduced AI-assisted vascular imaging system in 2023: Terumo’s AI-integrated diagnostic platform increased imaging precision by over 40%, helping clinicians detect vascular anomalies more accurately. Within the first year, it was adopted by over 25% of large hospitals in Asia-Pacific, particularly for complex lesion assessments.
• Abbott Laboratories received clearance for next-gen EVAR device in 2024: Abbott's new EVAR stent graft was launched with a repositionable delivery system, enhancing surgical flexibility. It recorded over 50% faster deployment and reduced operating time in 30% of clinical trial cases, and is now in use in over 20 countries globally.
• Penumbra Inc. rolled out thrombectomy device update in 2023: Penumbra enhanced its vascular aspiration system with increased clot removal efficiency, used in over 45% of acute limb ischemia cases within six months. Early adoption in more than 30% of U.S. vascular clinics highlighted its effectiveness in emergency settings.

Report Coverage

The report on the Peripheral Vascular Devices Market provides a detailed analysis of various aspects including market trends, device types, application areas, regional performance, competitive landscape, and investment opportunities. The study covers over 20 major manufacturers, profiling their strategic developments, product pipelines, and global footprint. Around 60% of the market is concentrated in North America and Europe, with Asia-Pacific emerging as the fastest-growing region, contributing nearly 25% of the market dynamics. The report includes segmentation data for more than 8 device types and 2 key applications, identifying usage patterns and technological preferences across clinical settings. More than 45% of hospitals and ambulatory centers globally are evaluated for device adoption trends, and over 50% of market data is derived from secondary research validated through expert interviews. The report also highlights recent innovations, with over 35% of new developments focused on imaging and AI-enabled devices. Strategic investment patterns and regulatory challenges are also mapped, offering a comprehensive view of growth pathways and risks.